Meeting
2017 Gastrointestinal Cancers Symposium
Prognostic value of PD-L1 expression in colorectal cancer.
Authors
Albert Y. Lin
VA Palo Alto Health Care System, Palo Alto, CA
Albert Y. Lin , Natalia B. Kouzminova , Thomas Chou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 610)
DOI
10.1200/JCO.2017.35.4_suppl.610
Abstract #
610
Poster Bd #
E6
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Prognostic role of microRNA-34a expression in colorectal cancer.
First Author: Albert Y. Lin
First Author: Hiroyuki Arai
Poster
2022 ASCO Annual Meeting
FoRT 05-BEAT: A phase II randomized trial comparing atezolizumab versus atezolizumab + bevacizumab as first-line treatment in patients with PD-L1 high advanced/metastatic NSCLC.
First Author: Rita Migliorino
Poster
2022 ASCO Annual Meeting
Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer.
First Author: Arielle Elkrief